CHARMY PET™ ANNOUNCES FIRST LINE OF FREEZE DRIED RAW PET FOOD IN NORTH AMERICA TO USE TRADITIONAL CHINESE MEDICINE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. TORONTO, ON, June 28, 2022 (GLOBE NEWSWIRE) — Charmy…

dvm360® Announces Winners of Second Annual Veterinary Heroes™ Recognition Program | News

CRANBURY, NJ, June 22, 2022 (GLOBE NEWSWIRE) — dvm360®, the leading multimedia provider of animal health care communications, education and research for veterinary professionals, is delighted to announce the winners…

dvm360® Announces Winners of Second Annual Veterinary Heroes™ Recognition Program

dvm360® dvm360® Announces Winners of Second Annual Veterinary Heroes™ Recognition Program Logo for the dvm360® Veterinary Heroes™ Recognition Program CRANBURY, NJ, June 22, 2022 (GLOBE NEWSWIRE) — dvm360®, the leading…

dvm360® Announces 2022-2023 Continuing Education Conference Lineup for Veterinary Professionals | News

CRANBURY, NJ, June 21, 2022 (GLOBE NEWSWIRE) — dvm360®, the leading multimedia provider of animal health care communications, education and research for veterinary professionals, today announced its 2022-2023 continuing education…

Ankyra Therapeutics Announces Research Collaboration with the College of Veterinary Medicine at the University of Illinois at Urbana-Champaign

BOSTON–(BUSINESS WIRE)–Ankyra Therapeutics is pleased to announce that it has entered into a formal research collaboration with the College of Veterinary Medicine at the University of Illinois Urbana-Champaign. Ankyra is…

NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neuron Disease

£2.68 million Biomedical Catalyst (BMC) early-stage award funded in part by Innovate UK to support development of disease-modifying medicines for debilitating chronic neurodegenerative disorders NRG has a pipeline of brain-penetrant…

NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neuron Disease

£2.68 million Biomedical Catalyst (BMC) early-stage award funded in part by Innovate UK to support development of disease-modifying medicines for debilitating chronic neurodegenerative disorders NRG has a pipeline of brain-penetrant…

HydroWorx Announces Expansion into Veterinary Medicine- Offering Premier Hydrotherapy to Pets

HydroWorx Pet Therapy Line debuts K900. “There are many therapeutic benefits of hydrotherapy, particularly with an underwater treadmill. As we continue to focus on harnessing the power of water to…

HydroWorx Announces Expansion into Veterinary Medicine- Offering Premier Hydrotherapy to Pets | News

Hydrotherapy company specializing in the rehabilitation of collegiate and professional athletes, pediatrics, and aging adults launches new product line for pet rehabilitation. MIDDLETOWN, Pa., May 27, 2022 /PRNewswire-PRWeb/ — HydroWorx,…

Jaguar Health Announces Napo Therapeutics’ Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition

Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to significant morbidity and mortality from severe secretory diarrhea SAN FRANCISCO,…